{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:06:35Z","timestamp":1792148795758,"version":"4.4.0"},"reference-count":30,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Education, Science, and Technological Development of Republic of Serbia","award":["451-03-9\/2021-14\/200110"],"award-info":[{"award-number":["451-03-9\/2021-14\/200110"]}]},{"name":"Ministry of Education, Science, and Technological Development of Republic of Serbia","award":["175023"],"award-info":[{"award-number":["175023"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Febrile neutropenia (FN) is a life-threatening complication in cancer patients, necessitating early risk stratification for optimal management. While the Multinational Association for Supportive Care in Cancer (MASCC) risk index is commonly used for mortality prediction, novel biomarkers that integrate inflammatory and nutritional status may improve prognostic accuracy. This study evaluates the mean platelet volume (MPV)-to-albumin (ALB) ratio as a predictor of mortality in patients with febrile neutropenia. Materials and Methods: A prospective study was conducted on patients diagnosed with febrile neutropenia. The MPV\/ALB ratio was calculated at admission, and its predictive value for mortality was assessed using receiver operating characteristic (ROC) curve analysis. The results were compared with the MASCC risk index for predicting mortality both during the FN episode and within 28 days. Statistical analysis included sensitivity, specificity, and negative predictive value assessments. Results: The MPV\/ALB ratio was significantly lower in non-survivors compared to survivors. A threshold of 0.245 effectively stratified patients at high risk, demonstrating strong specificity and high negative predictive value. The MPV\/ALB ratio outperformed the MASCC risk index in predicting mortality during febrile neutropenia, whereas the MASCC index showed slightly better performance for 28-day mortality prediction. Conclusions: The MPV\/ALB ratio is a promising biomarker for mortality prediction in febrile neutropenia, offering a simple and accessible tool for early risk assessment. Its superior performance in predicting mortality during FN highlights its potential clinical utility. Further prospective studies are needed to validate these findings and explore the integration of the MPV\/ALB ratio into existing risk assessment models.<\/jats:p>","DOI":"10.3390\/medicina61040601","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T11:01:00Z","timestamp":1743073260000},"page":"601","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mean Platelet Volume-to-Albumin Ratio as a Predictor of Mortality in Patients with Febrile Neutropenia: An Observational Study"],"prefix":"10.3390","volume":"61","author":[{"given":"Jelena","family":"Dimitrijevi\u0107","sequence":"first","affiliation":[{"name":"Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"\u010calama\u0107","sequence":"additional","affiliation":[{"name":"Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ognjen","family":"\u0110urmez","sequence":"additional","affiliation":[{"name":"Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2097-7591","authenticated-orcid":false,"given":"Marko","family":"Stojanovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3892\/mco.2015.524","article-title":"Epidemiology and characteristics of febrile neutropenia in oncology patients from Spanish tertiary care hospitals: PINNACLE study","volume":"3","author":"Tejerina","year":"2015","journal-title":"Mol. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1086\/383050","article-title":"Management of fever in neutropenic patients with different risks of complications","volume":"39","author":"Klastersky","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1002\/cam4.2955","article-title":"Mortality and admission to intensive care units after febrile neutropenia in patients with cancer","volume":"9","author":"Aagaard","year":"2020","journal-title":"Cancer Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.6004\/jnccn.2017.7010","article-title":"Risk of Febrile Neutropenia Associated With Select Myelosuppressive Chemotherapy Regimens in a Large Community-Based Oncology Practice","volume":"15","author":"Li","year":"2017","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/hon.2040","article-title":"Risk factors associated with complications in patients with chemotherapy-induced febrile neutropenia in emergency department","volume":"31","author":"Lynn","year":"2013","journal-title":"Hematol. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1007\/s00520-019-04925-8","article-title":"The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy","volume":"27","author":"Zecha","year":"2019","journal-title":"Support. Care Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1007\/s00520-013-1787-6","article-title":"Adding procalcitonin to the MASCC risk-index score could improve risk stratification of patients with febrile neutropenia","volume":"21","author":"Ahn","year":"2013","journal-title":"Support. Care Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/oncolo\/oyac074","article-title":"Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed?","volume":"27","author":"Boccia","year":"2022","journal-title":"Oncologist"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1007\/s00520-017-3776-7","article-title":"Can complications in febrile neutropenia be predicted? Report from a developing country","volume":"25","author":"Oberoi","year":"2017","journal-title":"Support. Care Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Coyne, C.J., Castillo, E.M., Shatsky, R.A., and Chan, T.C. (2022). Procalcitonin as a Predictive Tool for Death and ICU Admission among Febrile Neutropenic Patients Visiting the Emergency Department. Medicina, 58.","DOI":"10.3390\/medicina58080985"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4274\/tjh.galenos.2023.2023.0185","article-title":"Etiology and Factors Affecting Severe Complications and Mortality of Febrile Neutropenia in Children with Acute Leukemia","volume":"40","author":"Akans","year":"2023","journal-title":"Turk. J. Haematol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"11795549241281330","DOI":"10.1177\/11795549241281330","article-title":"Serum Albumin as a Prognostic Biomarker for Febrile Neutropenia Outcome and Complications: A Prospective Observational Trial","volume":"18","year":"2024","journal-title":"Clin. Med. Insights Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"107074","DOI":"10.1016\/j.ejso.2023.107074","article-title":"Malnutrition in cancer patients: Causes, consequences and treatment options","volume":"50","author":"Arends","year":"2024","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"9213074","DOI":"10.1155\/2019\/9213074","article-title":"Mean Platelet Volume (MPV): New Perspectives for an Old Marker in the Course and Prognosis of Inflammatory Conditions","volume":"2019","author":"Korniluk","year":"2019","journal-title":"Mediat. Inflamm."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Keller, U. (2019). Nutritional Laboratory Markers in Malnutrition. J. Clin. Med., 8.","DOI":"10.3390\/jcm8060775"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Enkobahry, A., Sime, T., Kene, K., Mateos, T., Dilnesa, S., and Zawdie, B. (2023). Blood biomarkers as potential malnutrition screening alternatives among adult patients with cancer on treatment in oncology unit of jimma tertiary hospital: A cross-sectional analysis. BMC Nutr., 9.","DOI":"10.1186\/s40795-023-00694-0"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Yan, X., Zhang, S., Jia, J., Yang, J., Song, Y., and Duan, H. (2022). Total Parenteral Nutrition Treatment Improves the Nutrition Status of Gynecological Cancer Patients by Improving Serum Albumin Level. Front. Med., 8.","DOI":"10.3389\/fmed.2021.759387"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jpen.1451","article-title":"Hypoalbuminemia: Pathogenesis and Clinical Significance","volume":"43","author":"Soeters","year":"2019","journal-title":"J. Parenter. Enter. Nutr."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Shmuely, H., Monely, L., and Shvidel, L. (2023). All-Cause Mortality and Its Predictors in Haemato-Oncology Patients with Febrile Neutropenia. J. Clin. Med., 12.","DOI":"10.3390\/jcm12175635"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ijregi.2021.09.002","article-title":"Mortality-associated clinical risk factors in patients with febrile neutropenia: A retrospective study","volume":"1","author":"Sereeaphinan","year":"2021","journal-title":"IJID Reg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jiph.2018.12.006","article-title":"Epidemiology and source of infection in patients with febrile neutropenia: A ten-year longitudinal study","volume":"12","author":"Hinedi","year":"2019","journal-title":"J. Infect. Public. Health"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Parodi, R.L., Lagrutta, M., Tortolo, M., Navall, E., Rodr\u00edguez, M.S., Sasia, G.F., De Candia, L.F., Gruvman, M.A., Bottasso, O., and Greca, A.A. (2019). A multicenter prospective study of 515 febrile neutropenia episodes in Argentina during a 5-year period. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0224299"},{"key":"ref_23","first-page":"S53","article-title":"Factors Associated with Survival Outcomes of Febrile Neutropenia in Hematologic Malignancy Patients","volume":"99","author":"Weerasubpong","year":"2016","journal-title":"J. Med. Assoc. Thai"},{"key":"ref_24","first-page":"4370834","article-title":"The Role of Mean Platelet Volume as a Predictor of Mortality in Critically Ill Patients: A Systematic Review and Meta-Analysis","volume":"2016","author":"Tajarernmuang","year":"2016","journal-title":"Crit. Care Res. Pract."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Jellinge, M.E., Henriksen, D.P., Hallas, P., and Brabrand, M. (2014). Hypoalbuminemia is a strong predictor of 30-day all-cause mortality in acutely admitted medical patients: A prospective, observational, cohort study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0105983"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.amjmed.2017.07.020","article-title":"Low Albumin Levels Are Associated with Mortality Risk in Hospitalized Patients","volume":"130","author":"Akirov","year":"2017","journal-title":"Am. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4097\/kja.21209","article-title":"Receiver operating characteristic curve: Overview and practical use for clinicians","volume":"75","author":"Nahm","year":"2022","journal-title":"Korean J. Anesthesiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/0301-4738.37595","article-title":"Understanding and using sensitivity, specificity and predictive values","volume":"56","author":"Parikh","year":"2008","journal-title":"Indian. J. Ophthalmol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1136\/bmj.308.6943.1552","article-title":"Diagnostic tests 1: Sensitivity and specificity","volume":"308","author":"Altman","year":"1994","journal-title":"BMJ"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/bmj.309.6947.102","article-title":"Diagnostic tests 2: Predictive values","volume":"309","author":"Altman","year":"1994","journal-title":"BMJ"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/4\/601\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:00:35Z","timestamp":1760029235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/4\/601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["medicina61040601"],"URL":"https:\/\/doi.org\/10.3390\/medicina61040601","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]}}}